''...Heather Bresch, president of the generic **** giant Mylan, says the shortages grow out of a sweeping consolidation of the generic **** industry into a few behemoths that compete only on price and have foreign plants that are rarely inspected.
“The race to the bottom has led to an increase of products coming from plants in China and India that may have uncertain supply and may have never been inspected,” Ms. Bresch said. “If the F.D.A. was required to inspect foreign **** plants at the same rate it does domestic ones, we might not have so many of these shortages...”
